Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease

Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease

10.1016/j.expneurol.2016.01.019

Saved in:

Bibliographic Details
Main Authors:	Garcia-Miralles, Marta, Ooi, Jolene, Bardile, Costanza Ferrari, Tan, Liang Juin, George, Maya, Drum, Chester L, Lin, Rachel Yanping, Hayden, Michael R, Pouladi, Mahmoud A
Other Authors:	DEAN'S OFFICE (MEDICINE)
Format:	Article
Language:	English
Published:	ACADEMIC PRESS INC ELSEVIER SCIENCE 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Neurosciences Neurosciences & Neurology Huntington's disease Monoamine oxidase Monoamine oxidase inhibitors Mouse model Psychiatric features Depression Anxiety Monoamines HIPPOCAMPAL NEUROGENESIS GENE CARRIERS OXIDASE DEPRESSION DYSFUNCTION BEHAVIOR ANXIETY LITHIUM MICE PATHOGENESIS
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/234700
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Be the first to leave a comment!